Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2021 Jul 19;11:734761. doi: 10.3389/fonc.2021.734761

Retraction: ECT2 Increases the Stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer

Frontiers Editorial Office1,*
PMCID: PMC8327263  PMID: 34350126

The Journal and Authors retract the 8 February 2021 article cited above for the following reasons provided by the Authors:

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.

This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES